Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 26, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Tritium labeled ketamine metabolites (R-ketamine, S-ketamine and RR-HNK)

Closed
25-004566Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), is seeking to procure tritium-labeled versions of R-ketamine, S-ketamine, and RR-HNK to support research into their pharmacological properties and mechanisms of action. This project aims to develop key reagents—specifically 5 millicuries of each compound—to facilitate autoradiography studies that will enhance understanding of these bioactive small molecules, which are being explored for their potential therapeutic effects across various disease indications. The contract is set to be performed within five months of award, emphasizing a rapid timeline for delivering these specialized labeled compounds. The solicitation, posted in August 2025, is a combined type with no set-aside restrictions, under NAICS code 541380, which pertains to testing laboratories and related services. The contract will be managed by the NIH's Office in Maryland, with primary contact being Brian Lind. Interested parties are invited to respond by September 9, 2025, and further details can be accessed through the provided link. This initiative underscores NIH’s ongoing commitment to advancing translational science by developing innovative tools to better understand and potentially treat various health conditions.

General Info

NIH contract to deliver tritium-labeled ketamine compounds for pharmacological research by September 2025.

NAICS

541380 - Testing Laboratories and Services

Place of Performance

MD, 20850, USA

Set-Aside

NONE

Documents

1

Purchase Description for Radiolabeled Ketamine Metabolites

DOCX, High priority: read this first1 page · sow
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Ncats
Contacts1 person available
OfficeRockville, MD, 20850, USA
Office AddressRockville, MD, 20850, USA

Full Description

Show more
The National Institutes of Health (NIH) is the nation's leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people's health and save lives. The National Center for Advancing Translational Sciences (NCATS) is a translational science center that prides itself on its tremendously productive pipeline and is innovative in a number of ways. One of these ways is the development of new Bioactive Small Molecules which can modulate key biological pathways in multiple disease indications. This bioactive small molecule project is one of the key projects that progresses the study of RR-HNK from a mechanistic and pharmacological perspective. The tritium labeled version of R-ketamine, S-ketamine and RR-HNK will provide key reagents for the study of the pharmacology of all 3 agents. General description: Labeled R and S Ketamine and 2R,6R-HNK Specific description: 5 mCi of R and S Ketamine and 2R,6R-HNK to conduct autoradiography work in support of our RR-HNK program. Period of Performance is within five (5) months from the award of contract.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS